SIGIRR / TIR8: A Negative Regulator of Toll-IL-1R Signaling

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 16, 3 Issues, 2017

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

SIGIRR / TIR8: A Negative Regulator of Toll-IL-1R Signaling

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 4(1): 21-27.

Author(s): Xiaoxia Li and Jinzhong Qin.

Affiliation: Department of Immunology, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 EuclidAvenue, Cleveland, Ohio 44195, USA.


Toll-like receptors (TLRs) belong to the Toll-IL-1 receptor superfamily, which is defined by a common intracellular Toll-IL-1 receptor (TIR)-domain. These receptors employ related yet distinct signaling components and downstream pathways, leading to activation of the transcription factors NFkB, ATF and IRF3. Recent studies have also begun to unravel how these pathways are negatively regulated. SIGIRR (also known as TIR8), a member of Toll-IL-1R superfamily that does not activate the transcription factors NFkB, ATF and IRF3, instead negatively modulates responses. Inflammation is enhanced in SIGIRR-null mice as measured by enhanced chemokine induction after IL-1 injection and a reduced threshold for lethal endotoxin challenge. SIGIRR-deficient mice are more susceptible to DSS-induced inflammatory bowel disease. Cells from SIGIRR-null mice show enhanced activation in response to either IL-1 or certain Toll ligands. Therefore, SIGIRR functions as a biologically important modulator of Toll-IL-1R signaling.


innate immunity, toll-like, receptors, signaling.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 4
Issue Number: 1
First Page: 21
Last Page: 27
Page Count: 7
DOI: 10.2174/1568014053005309
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science